Source: Eur Respir J, 51 (5) 1800730; 10.1183/13993003.00730-2018
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
William W. Busse. Are peripheral blood eosinophil counts a guideline for omalizumab treatment? STELLAIR says no!. Eur Respir J, 51 (5) 1800730; 10.1183/13993003.00730-2018

Member's Comments

No comment yet.

Related content which might interest you: Analysis of IMPACT: is one blood eosinophil count measurement sufficient to predict ICS treatment response in COPD? Source: International Congress 2019 – COPD clinical trials: new molecules and novel insights Year: 2019 COPD treatment choices based on blood eosinophils: are we there yet? Source: Breathe, 15 (4) 318; 10.1183/20734735.0254-2019 Year: 2019 Association between blood eosinophil count and control of allergic rhinitis: does it exist? Source: International Congress 2019 – COPD, asthma and rhinitis: from cellular mechanisms to patients’ clinical responses Year: 2019 Response to omalizumab treatment according to blood eosinophil count: Results of a French real-world study (STELLAIR) Source: International Congress 2017 – Asthma: mechanisms and treatment Year: 2017 Peripheral blood eosinophil counts in COPD patients and its relationship with prescription of inhaled corticosteroid in real world setting in Japan. Source: International Congress 2017 – Airway disease and exacerbations Year: 2017 Budesoinde/formoterol: does eosinophil count cause different outcomes? Source: International Congress 2019 – Asthma: outcomes of clinical trials and cohorts Year: 2019 A single blood eosinophil count measurement is as good as two for prediction of ICS treatment response in the IMPACT trial Source: Eur Respir J, 58 (3) 2004522; 10.1183/13993003.04522-2020 Year: 2021 Omalizumab effectiveness in patients with severe allergic asthma according to blood eosinophil count: the STELLAIR study Source: Eur Respir J, 51 (5) 1702523; 10.1183/13993003.02523-2017 Year: 2018 Mepolizumab does not alter blood basophil count in severe asthma Source: International Congress 2019 – COPD, asthma and rhinitis: from cellular mechanisms to patients’ clinical responses Year: 2019 ERJ October Podcast: blood eosinophil count as a biomarker in patients with airway disease Source: Eur Respir J 2016; 48: E70 Year: 2016 Peripheral eosinophil count as a biomarker for the management of COPD: not there yet Source: Eur Respir J, 50 (5) 1702165; 10.1183/13993003.02165-2017 Year: 2017 Could eosinophil / neutrophil ratio be used to determine treatment in COPD patients? Source: International Congress 2018 – Biomarkers for evaluating COPD Year: 2018 The blood eosinophil count as a biomarker in COPD Source: International Congress 2015 – Individualised risk reduction strategies for patients with COPD Year: 2015 What can we learn from blood granulocyte patterns in patients with asthma? Source: Eur Respir J 2016; 48: 976-978 Year: 2016 Late Breaking Abstract - The blood eosinophils count as a predictor of the response for omalizumab (OMA) in patients suffering from severe allergic asthma Source: International Congress 2019 – Blood eosinophils and more in airway diseases Year: 2019 Late Breaking Abstract - Lack of stability of blood eosinophil counts in patients with COPD. Source: International Congress 2019 – Blood eosinophils and more in airway diseases Year: 2019 Long-term omalizumab treatment – do drug concentration levels count? Source: Virtual Congress 2020 – Personalised treatment of obstructive diseases Year: 2020 One year monitoring of children with bronchial asthma and other allergic diseases treated with inhaled corticosteroids vs cromoglycates with serum ECP (S-ECP), FEV1, total IgE and blood eosinophil count - the influence of different therapy Source: Eur Respir J 2002; 20: Suppl. 38, 432s Year: 2002 Blood eosinophils fluctuation in asthmatics on Omalizumab-a mirror of disease outcomes improvement? Source: International Congress 2018 – Biomarkers for evaluating asthma Year: 2018 Blood eosinophil count as a predictor of treatment response in adult patients with chronic cough Source: Virtual Congress 2020 – Asthma and cough: clinical trials and pharmacological insights Year: 2020